Gauss Surgical Secures $20 Million Series C Funding to Expand Triton, Its AI-Powered Surgical Blood Loss Monitoring Platform, Now Deployed in 50 U.S. Hospitals

VCBeat (WeChat ID: VCbeat) has learned that on October 17, 2018, Gauss Surgical (“Gauss”), an AI-driven healthcare technology company headquartered in California, USA, announced the closing of a $20 million Series C financing round. The round was led by Northwell Health, SoftBank Ventures Korea, LS Polaris Innovation Fund, and seven other leading U.S. healthcare groups.

This round of funding will be used to accelerate the adoption of its flagship product, the Triton app for intelligent monitoring of surgical blood loss, in hospitals, as well as to develop new smart operating room applications.

Gauss Surgical has previously completed six rounds of financing, totaling $31.5 million, with annual revenue exceeding $5 million. The latest valuation has not been disclosed.

Over the past 15 years, preventable maternal deaths and harmful postpartum health complications among mothers in the United States have surged due to undetected hemorrhage, particularly following cesarean deliveries. A recent study published in the American Journal of Perinatology, involving 2,781 patients who underwent cesarean sections, demonstrated that implementing Triton significantly enhances awareness of maternal hemorrhage and markedly reduces blood loss and patient hospital stays.

Triton has received re-approval from the U.S. Food and Drug Administration (FDA) and obtained European CE certification.

Reports indicate that Trito is gaining increasingly widespread adoption in the United States, currently being utilized by 50 hospitals and applied in over 200,000 infant deliveries annually. Among these adopters is Northwell Health, a key investor in the company. As one of the largest healthcare systems in the U.S., Northwell Health treats more than 2 million patients each year across the New York metropolitan area, with an annual operating budget nearing $12 billion.

“Gauss has demonstrated a tangible impact on improving the quantification of blood loss in obstetric patients and is helping to enhance our management of postpartum hemorrhage. Reducing maternal mortality and morbidity has become a top patient safety priority for Northwell and hospitals across the United States,” said Ellie McGuire, Co-Founder of the LS Polaris Innovation Fund.

Gauss is a technology company based in Silicon Valley, USA, that pioneered the wireless transmission model for medical technology. The company leverages computer vision and machine learning to provide mobile applications for operating rooms, with a focus on enhancing patient safety, surgical quality, and outcomes. Its initial product, Triton, is a real-time blood loss monitor that improves patient care and reduces hospital costs.

Northwell Health is the largest healthcare provider and private employer in New York State, with 23 hospitals, 665 outpatient facilities, and more than 18,500 affiliated physicians.

SoftBank Ventures Korea, established in 2000, is the sole global early-stage venture capital firm of SoftBank Group in Seoul, South Korea. The firm primarily invests in high-potential startups across Asia, the United States, Israel, and the European Union, with a focus on artificial intelligence, the Internet of Things (IoT), and intelligent robotics.